AUSTRALIAN PRODUCT RECALL

Ruzurgi Amifampridine 10 mg Tablet Bottle

Published 4 October 2021

Product

Ruzurgi amifampridine 10 mg tablet bottle Batch Number: 18039 Exp: 3/2023 Supplied via Special Access Scheme (SAS)

Why it was recalled

The affected product batch 18039 exceeds the specification for total yeast and mould counts (TYMC).

Hazard

The effects of increased exposure to yeast and/or mould can include allergic reactions, asthma, neurotoxicity, sinusitis, otomycosis, onychomycosis, keratitis, respiratory infections, skin infections, and systemic infections. This may pose a serious health risk to users with weakened immune systems.  

Read the official notice ↗

Source: Based on ACCC data or other content. ACCC © Commonwealth of Australia. ACCC-owned material is licensed under CC BY 4.0. RecallMatch extracts and formats notice information for screening. Third-party material may have separate rights. Source and reuse terms. Verify details in the official notice. RecallMatch is independent of the ACCC.